EUVIMEDEUVIMED entdecken
Crossref

A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients

My-Luong Vuong, Omar Elkayal, Ruth Van Daele, Jan-Willem C Alffenaar, Sophie L Stocker, Jason A Roberts, Yves Debaveye, Joost Wauters, Beatrijs Mertens, Jasper M Boonstra, Indy Sandaradura, Deborah J E Marriott und 6 weitere

Infection · 2026-02 · 54 (1) · 299-313

DOI: 10.1007/s15010-025-02663-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection, online erschienen am 14.10.2025. Verfasst von My-Luong Vuong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, ON2 Herestraat 49 box 521, Leuven, 3000, Belgium. Hauptthemen laut MEDLINE: Fluconazole, Antifungal Agents, Candidiasis, Invasive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Fluconazole is the recommended step-down therapy from echinocandins for fluconazole-susceptible Candida spp in critically ill patients with invasive candidiasis. However, standard fluconazole dosing does not achieve adequate exposure in these patients. We aimed to identify factors impacting fluconazole pharmacokinetic-pharmacodynamic (PKPD) target attainment and provide a dosing regimen ensuring adequate target attainment in critically ill patients. METHODS: A population pharmacokinetics study (popPK) was conducted, combining fluconazole concentration data from eight studies. We used multiple imputation to handle missing covariate data, and Monte Carlo simulations to identify a dosing regimen with at least 90% probability of PKPD target attainment (PTA) in every patient. The PKPD target is the 24-hour area under the unbound concentration-time curve over the minimum inhibitory concentration of 100. RESULTS: Data from 177 critically ill patients were included. A two-compartment popPK model with linear elimination described the data best. Continuous renal replacement therapy (CRRT) status, estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration creatinine equation, and total body weight were statistically significant covariates. However, with standard dosing, only CRRT status and total body weight were clinically relevant, as PTA dropped below 90% for all patients on CRRT, and for patients off-CRRT above 60 kg. A weight-based loading dose and flat maintenance doses of 400 mg (off-CRRT) and 800 mg (CRRT) predicted ≥ 90% PTA across the weight range. CONCLUSION: We have developed a fluconazole dosing regimen, stratified by weight and CRRT status, that may achieve adequate PTA in critically ill patients. External validation is awaited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluconazoleAntifungal AgentsCandidiasis, InvasiveHumansCritical IllnessMaleFemaleMiddle AgedAgedMicrobial Sensitivity TestsAdultAged, 80 and overMonte Carlo Method

Stichwörter der Autor:innen

AntifungalsCandidaemiaCritical illnessPharmacokinetic-Pharmacodynamic

Substanzen

FluconazoleAntifungal Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, ON2 Herestraat 49 box 521, Leuven, 3000, Belgium.
  • Novo Nordisk, Copenhagen, Denmark.
  • Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
  • Gilead Sciences, Diegem, Belgium.
  • School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Pharmacy Department, Westmead Hospital, Sydney, Australia.

Förderung

  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Vuong, M. L., Elkayal, O., Van Daele, R., Alffenaar, J. C., Stocker, S. L., Roberts, J. A., Debaveye, Y., Wauters, J., Mertens, B., Boonstra, J. M., Sandaradura, I., Marriott, D. J. E., Brüggemann, R. J., Schouten, J. A., Bergner, R., Buijk, S., Spriet, I., & Dreesen, E. (2026). A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients. Infection, 54(1), 299-313. https://doi.org/10.1007/s15010-025-02663-0

Vancouver

Vuong ML, Elkayal O, Van Daele R, Alffenaar JC, Stocker SL, Roberts JA, et al. A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients. Infection. 2026;54(1):299-313. doi:10.1007/s15010-025-02663-0

BibTeX
@article{Vuong2026,
  author = {Vuong, My-Luong and Elkayal, Omar and Van Daele, Ruth and Alffenaar, Jan-Willem C and Stocker, Sophie L and Roberts, Jason A and Debaveye, Yves and Wauters, Joost and Mertens, Beatrijs and Boonstra, Jasper M and Sandaradura, Indy and Marriott, Deborah J E and Brüggemann, Roger J and Schouten, Jeroen A and Bergner, Raoul and Buijk, Steven and Spriet, Isabel and Dreesen, Erwin},
  title = {A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients},
  journal = {Infection},
  year = {2026},
  volume = {54},
  number = {1},
  pages = {299--313},
  doi = {10.1007/s15010-025-02663-0}
}
Kostenlos starten →